DIA
DNLI icon

Dana Investment Advisors’s Denali Therapeutics DNLI Stock Holding History

Dana Investment Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
59,971
+8,049
+16% +$165K 0.04% 379
2026
Q1 		$997K Buy
51,922
+1,340
+3% +$26.7K 0.03% 405
2025
Q4 		$835K Sell
50,582
-134
-0.3% -$2.26K 0.02% 413
2025
Q3 		$736K Buy
50,716
+15,155
+43% +$218K 0.02% 430
2025
Q2 		$497K Buy
35,561
+3,406
+11% +$47.9K 0.02% 454
2025
Q1 		$437K Sell
32,155
-2,147
-6% -$41.1K 0.02% 461
2024
Q4 		$699K Sell
34,302
-550
-2% -$14.1K 0.02% 426
2024
Q3 		$1.02M Buy
34,852
+583
+2% +$14.5K 0.03% 379
2024
Q2 		$796K Buy
34,269
+5,513
+19% +$106K 0.03% 400
2024
Q1 		$590K Buy
28,756
+4,699
+20% +$88.3K 0.02% 422
2023
Q4 		$516K Sell
24,057
-572
-2% -$11.3K 0.02% 322
2023
Q3 		$508K Sell
24,629
-2,430
-9% -$61.6K 0.03% 311
2023
Q2 		$799K Buy
27,059
+260
+1% +$7.31K 0.04% 261
2023
Q1 		$617K Buy
26,799
+1,683
+7% +$46.3K 0.03% 287
2022
Q4 		$698K Buy
25,116
+4,719
+23% +$140K 0.04% 277
2022
Q3 		$626K Buy
20,397
+7,047
+53% +$229K 0.04% 278
2022
Q2 		$393K Buy
13,350
+2,054
+18% +$53.8K 0.02% 352
2022
Q1 		$363K Buy
11,296
+1,658
+17% +$57.1K 0.02% 294
2021
Q4 		$430K Buy
9,638
+326
+4% +$15.4K 0.02% 268
2021
Q3 		$470K Buy
+9,312
New +$525K 0.02% 253

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dana Investment Advisors's DNLI Position: Q2 2026 in Review

Dana Investment Advisors increased its Denali Therapeutics (DNLI) stake by 16% in Q2 2026, buying an estimated $165K and bringing the position to 59,971 shares worth $1.54M. The position accounts for 0.04% of the portfolio, ranked #379.

Dana Investment Advisors first reported a position in DNLI in Q3 2021 and has held it in 20 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Dana Investment Advisors held 59,971 shares of Denali Therapeutics worth $1.54M as of Q2 2026.
  • Dana Investment Advisors bought 8,049 Denali Therapeutics shares in Q2 2026, an estimated $165K.
  • Denali Therapeutics made up 0.04% of Dana Investment Advisors's portfolio in Q2 2026, its #379 holding.
  • Dana Investment Advisors first reported a position in Denali Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.